Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - PLURISTEM THERAPEUTICS INC | f10q1220ex32-2_pluristem.htm |
| EX-31.2 - CERTIFICATION - PLURISTEM THERAPEUTICS INC | f10q1220ex31-2_pluristem.htm |
| EX-31.1 - CERTIFICATION - PLURISTEM THERAPEUTICS INC | f10q1220ex31-1_pluristem.htm |
| EX-10.1 - FORM OF DIRECTOR AND OFFICER INDEMNIFICATION AGREEMENT - PLURISTEM THERAPEUTICS INC | f10q1220ex10-1_pluristem.htm |
| 10-Q - QUARTERLY REPORT - PLURISTEM THERAPEUTICS INC | f10q1220_pluristem.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Quarterly Report (the “Report”) of Pluristem Therapeutics Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof, I, Yaky Yanay, Chief Executive Officer and President of the Company, certify, pursuant to 18 U.S.C. 1350, that to my knowledge:
| 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: February 8, 2021 | By: | /s/ Yaky Yanay |
| Yaky Yanay | ||
| Chief Executive Officer and President | ||